Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
Latest reported ALLO revenue for 2026-06-30 was $4.6M. Net income was -$85.3M. ALLO currently screens at market cap $258.1M.
Use this ALLO page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ALLO quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ALLO SEC filings page. Lician reads the product cache first so this HTML stays unique to Allogene Therapeutics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full ALLO income, balance, and cash tables.